349 related articles for article (PubMed ID: 26215453)
21. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Vellaichamy E; Zhao D; Somanna N; Pandey KN
Physiol Genomics; 2007 Oct; 31(2):193-202. PubMed ID: 17566078
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
[TBL] [Abstract][Full Text] [Related]
23. Modulation of ANP-C receptor signaling by endothelin-1 in A-10 smooth muscle cells.
Boumati M; Li Y; Anand-Srivastava MB
Arch Biochem Biophys; 2002 May; 401(2):178-86. PubMed ID: 12054468
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.
Brown LA; Nunez DJ; Wilkins MR
J Clin Invest; 1993 Dec; 92(6):2702-12. PubMed ID: 7902846
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine impairs the guanylyl cyclase activity of the natriuretic peptide receptor in the glomerulus.
Kook H; Kim SW; Kang SY; Kim SZ; Kim JH; Choi KC; Lee J; Cho KW; Baik YH
Pharmacol Res; 2000 Nov; 42(5):435-41. PubMed ID: 11023705
[TBL] [Abstract][Full Text] [Related]
26. Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during β-adrenergic receptor activation-induced hypertrophic growth in rats.
Manivasagam S; Subramanian V; Tumala A; Vellaichamy E
Mol Cell Endocrinol; 2016 Sep; 433():117-29. PubMed ID: 27283501
[TBL] [Abstract][Full Text] [Related]
27. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
Bae EH; Ma SK; Lee J; Kim SW
Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-κB signal pathway in hepatocytes.
Zhao J; Liu J; Pang X; Wang S; Wu D; Zhang X; Feng L
Cell Physiol Biochem; 2013; 32(3):569-80. PubMed ID: 24021937
[TBL] [Abstract][Full Text] [Related]
29. Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth.
Itoh H; Pratt RE; Dzau VJ
Biochem Biophys Res Commun; 1991 May; 176(3):1601-9. PubMed ID: 1828153
[TBL] [Abstract][Full Text] [Related]
30. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A.
Joubert S; Jossart C; McNicoll N; De Léan A
FEBS J; 2005 Nov; 272(21):5572-83. PubMed ID: 16262696
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells.
Anand-Srivastava MB
Biochemistry; 2000 May; 39(21):6503-13. PubMed ID: 10828966
[TBL] [Abstract][Full Text] [Related]
33. Receptor-specific ligands distinguish natriuretic peptide receptors-A and -C in primate tissues.
Sehl P; Tom JY; Oare D; Lowe DG
Mol Cell Biochem; 1998 Jan; 178(1-2):317-24. PubMed ID: 9546616
[TBL] [Abstract][Full Text] [Related]
34. Triiodo-L-thyronine (T3) downregulates Npr1 gene (coding for natriuretic peptide receptor-A) transcription in H9c2 cells: involvement of β-AR-ROS signaling.
Nagaraj G; Vellaichamy E
Endocrine; 2024 May; ():. PubMed ID: 38713329
[TBL] [Abstract][Full Text] [Related]
35. Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells.
Cao L; Chen SC; Cheng T; Humphreys MH; Gardner DG
Am J Physiol; 1998 Jul; 275(1):F119-25. PubMed ID: 9689013
[TBL] [Abstract][Full Text] [Related]
36. Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells.
Liu JJ; Li DL; Zhou J; Sun L; Zhao M; Kong SS; Wang YH; Yu XJ; Zhou J; Zang WJ
Apoptosis; 2011 Jan; 16(1):94-103. PubMed ID: 20963497
[TBL] [Abstract][Full Text] [Related]
37. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Yu L; She T; Li M; Shi C; Han L; Cheng M
Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
[TBL] [Abstract][Full Text] [Related]
38. Effect of angiotensin II on ANP-dependent guanylyl cyclase activity in cultured mouse and rat podocytes.
Golos M; Lewko B; Bryl E; Witkowski JM; Dubaniewicz A; Olszewska A; Latawiec E; Angielski S; Stepinski J
Kidney Blood Press Res; 2002; 25(5):296-302. PubMed ID: 12435875
[TBL] [Abstract][Full Text] [Related]
39. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
